1 week Ago By ABMN Staff
Legal & General Group Plc lifted its holdings in Liquidia Co. ( NASDAQ:LQDA – Free Report ) by 6.5% in the 4th quarter, Holdings Channel.
com reports. The firm owned 83,286 shares of the company’s stock after purchasing an additional 5,048 shares during the quarter. Legal & General Group Plc’s holdings in Liquidia were worth $979,000 at the end of the most recent reporting period.
A number of other large investors also recently bought and sold shares of the business. Corebridge Financial Inc. increased its stake in shares of Liquidia by 2.
3% during the fourth quarter. Corebridge Financial Inc. now owns 31,516 shares of the company’s stock worth $371,000 after purchasing an additional 694 shares in the last quarter.
Catalina Capital Group LLC increased its stake in Liquidia by 6.5% during the 4th quarter. Catalina Capital Group LLC now owns 18,307 shares of the company’s stock worth $215,000 after buying an additional 1,125 shares in the last quarter.
Sigma Planning Corp raised its holdings in shares of Liquidia by 3.4% during the fourth quarter. Sigma Planning Corp now owns 65,210 shares of the company’s stock valued at $767,000 after acquiring an additional 2,115 shares during the last quarter.
DMC Group LLC lifted its position in shares of Liquidia by 17.4% in the fourth quarter. DMC Group LLC now owns 16,302 shares of the company’s stock valued at $192,000 after acquiring an additional 2,419 shares in the last quarter.
Finally, Arizona State Retirement System boosted its stake in shares of Liquidia by 20.3% in the fourth quarter. Arizona State Retirement System now owns 15,888 shares of the company’s stock worth $187,000 after acquiring an additional 2,685 shares during the last quarter.
Institutional investors and hedge funds own 64.54% of the company’s stock. Wall Street Analyst Weigh In A number of research analysts have weighed in on LQDA shares.
Scotiabank restated an “outperform” rating on shares of Liquidia in a report on Thursday, March 20th. HC Wainwright restated a “buy” rating and set a $29.00 price target on shares of Liquidia in a research report on Thursday, March 20th.
Finally, Needham & Company LLC reiterated a “buy” rating and issued a $25.00 price objective on shares of Liquidia in a report on Thursday, April 10th. One analyst has rated the stock with a hold rating, six have given a buy rating and two have assigned a strong buy rating to the stock.
According to MarketBeat.com, Liquidia currently has an average rating of “Buy” and a consensus target price of $26.63.
Insider Buying and Selling at Liquidia In other Liquidia news, CEO Roger Jeffs sold 14,130 shares of the business’s stock in a transaction dated Monday, April 14th. The shares were sold at an average price of $13.57, for a total transaction of $191,744.
10. Following the sale, the chief executive officer now directly owns 1,006,420 shares in the company, valued at $13,657,119.40.
This represents a 1.38 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website .
Also, insider Jason Adair sold 1,856 shares of the firm’s stock in a transaction that occurred on Monday, April 14th. The shares were sold at an average price of $13.57, for a total transaction of $25,185.
92. Following the completion of the transaction, the insider now directly owns 184,304 shares of the company’s stock, valued at approximately $2,501,005.28.
The trade was a 1.00 % decrease in their position. The disclosure for this sale can be found here .
Insiders sold a total of 32,683 shares of company stock worth $443,753 over the last three months. Insiders own 30.10% of the company’s stock.
Liquidia Stock Performance LQDA stock opened at $14.12 on Monday. Liquidia Co.
has a one year low of $8.26 and a one year high of $16.81.
The firm has a market cap of $1.20 billion, a PE ratio of -8.66 and a beta of 0.
23. The firm’s 50 day moving average price is $14.40 and its 200-day moving average price is $12.
92. Liquidia ( NASDAQ:LQDA – Get Free Report ) last posted its earnings results on Wednesday, March 19th. The company reported ($0.
46) EPS for the quarter, missing analysts’ consensus estimates of ($0.38) by ($0.08).
The business had revenue of $2.92 million during the quarter, compared to analysts’ expectations of $4.60 million.
Liquidia had a negative net margin of 765.38% and a negative return on equity of 163.21%.
Equities research analysts predict that Liquidia Co. will post -1.51 EPS for the current fiscal year.
Liquidia Company Profile ( Free Report ) Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). Recommended Stories Want to see what other hedge funds are holding LQDA? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for Liquidia Co. ( NASDAQ:LQDA – Free Report ). Receive News & Ratings for Liquidia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liquidia and related companies with MarketBeat.
com's FREE daily email newsletter ..
